| First Author | Lu M | Year | 2013 |
| Journal | PLoS Pathog | Volume | 9 |
| Issue | 5 | Pages | e1003339 |
| PubMed ID | 23675296 | Mgi Jnum | J:213407 |
| Mgi Id | MGI:5584278 | Doi | 10.1371/journal.ppat.1003339 |
| Citation | Lu M, et al. (2013) Persistently active microbial molecules prolong innate immune tolerance in vivo. PLoS Pathog 9(5):e1003339 |
| abstractText | Measures that bolster the resolution phase of infectious diseases may offer new opportunities for improving outcome. Here we show that inactivation of microbial lipopolysaccharides (LPS) can be required for animals to recover from the innate immune tolerance that follows exposure to Gram-negative bacteria. When wildtype mice are exposed to small parenteral doses of LPS or Gram-negative bacteria, their macrophages become reprogrammed (tolerant) for a few days before they resume normal function. Mice that are unable to inactivate LPS, in contrast, remain tolerant for several months; during this time they respond sluggishly to Gram-negative bacterial challenge, with high mortality. We show here that prolonged macrophage reprogramming is maintained in vivo by the persistence of stimulatory LPS molecules within the cells' in vivo environment, where naive cells can acquire LPS via cell-cell contact or from the extracellular fluid. The findings provide strong evidence that inactivation of a stimulatory microbial molecule can be required for animals to regain immune homeostasis following parenteral exposure to bacteria. Measures that disable microbial molecules might enhance resolution of tissue inflammation and help restore innate defenses in individuals recovering from many different infectious diseases. |
